Grassi v. Grassi

CourtDistrict Court, N.D. Ohio
DecidedApril 19, 2022
Docket1:18-cv-02619
StatusUnknown

This text of Grassi v. Grassi (Grassi v. Grassi) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Grassi v. Grassi, (N.D. Ohio 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF OHIO EASTERN DIVISION

MICHAEL GRASSI, et al., CASE NO. 1:18-CV-02619

Plaintiffs, -vs- JUDGE PAMELA A. BARKER

JOHN GRASSI, et al., MEMORANDUM OPINION AND Defendants. ORDER

This matter comes before the Court upon the Motion for Voluntary Dismissal Without Prejudice of Plaintiffs-Counterclaim Defendants Michael Grassi and CFOM, Inc. (“CFOM”) (collectively, “Plaintiffs”) filed on February 9, 2022. (Doc. No. 95.) Defendants-Counterclaimants John Grassi and Alotech Limited, LLC (“Alotech”) (collectively, “Defendants”) filed a Memorandum of Law in Opposition on February 23, 2022, to which Plaintiffs replied on March 2, 2022. (Doc. Nos. 96, 97.) For the following reasons, Plaintiffs’ Motion is DENIED. I. Relevant Background a. Factual Background1 This case arises out of a business dispute between twin brothers—John Grassi and Michael Grassi—regarding the development of a proprietary process for manufacturing alloy castings known as ablation casting. John Grassi is the founder and sole owner of Alotech, a company that began

1 The factual background of this matter is set forth in several previous decisions (see, e.g., Doc. Nos. 77, 83) and will not be repeated in full herein. Rather, the Court presumes familiarity with its prior opinions and will provide only a broad overview of the facts to place the instant Motion in context. developing the ablation casting process in the early 2000s. Between 2002 and 2009, Alotech continued to refine the ablation casting process and filed six patents related to the technology. Alotech used that technology to manufacture parts for other companies. Around 2000, Michael Grassi purchased and became the sole owner of CFOM, a company that manufactured valve equipment and mass flow controllers. In 2006, CFOM began supplying equipment to Alotech for use in its ablation casting process. Later, CFOM also began providing to

Alotech the services of Charles Rizzuti, who worked for CFOM and assisted Alotech with computer programming equipment. The parties dispute the amount to which CFOM and Michael Grassi are entitled from their contributions to the ablation casting technology. Plaintiffs assert that in 2008, John Grassi and Michael Grassi entered into an agreement to share any proceeds from their endeavors, with each brother receiving 50 percent of the proceeds. Then in 2012, according to Plaintiffs, the parties reached an oral agreement in which John Grassi agreed to share the proceeds of a potential deal between Alotech and Honda, with Alotech receiving 65 percent of the proceeds and CFOM receiving 35 percent of the proceeds. Defendants deny that this agreement occurred, and instead, claim that Alotech simply hired Michael Grassi as an employee. In April 2013, as anticipated, Alotech entered

into an agreement with Honda. Shortly after Michael Grassi started working full time on ablation casting technology in the fall of 2012, Defendants assert that he signed a form Confidentiality and Work Product Agreement (the “IP Agreement”). The IP Agreement provided that Alotech would own Michael Grassi’s work product and any value relating to ablation casting created by CFOM while Michael Grassi worked

2 for Alotech. Alotech’s files contain two copies of this agreement, one signed on October 22, 2012 and one signed on October 25, 2012. Michael Grassi alleges these signatures are forged. Michael Grassi also asserts that a third document allegedly signed by him—a June 2017 patent assignment (the “June 2017 Patent Assignment”)—was forged. The June 2017 Patent Assignment purports to assign to Alotech all rights in a pending patent application related to ablation casting. In late 2016, Michael Grassi, CFOM, and Rizzuti all ceased performing services or providing

equipment to Alotech in connection with the company’s ablation casting work because they believed they were not being paid their fair share from the Honda deal. Defendants contend that they fired Michael Grassi; Michael contends he was never an employee. Over the years, Defendants made hundreds of thousands of dollars in payments to Plaintiffs, but the parties disagree on the nature and purpose of those payments. Michael Grassi claims that these payments were merely reimbursements for costs and materials; he never received full compensation for his intellectual contributions to the ablation casting technology; and any money he did receive was a result of the alleged oral agreement. John Grassi disputes this and states that he paid Michael Grassi for improvements Michael made to the technology in connection with the Honda deal and for Michael’s salary during his employment with Alotech.

b. Procedural History i. Pretrial On October 9, 2018, Plaintiffs filed a Complaint against Defendants in the Court of Common Pleas of Cuyahoga County, Ohio, asserting six counts: (1) breach of contract, (2) promissory estoppel, (3) quantum meruit, (4) unjust enrichment, (5) fraud, and (6) misappropriation of trade secrets. (Doc.

3 No. 1-1.) Defendants removed the case to this Court on November 13, 2018 based on diversity jurisdiction. (Doc. No. 1.) On December 11, 2018, Defendants filed an Amended Answer, Affirmative Defenses to Plaintiffs’ Complaint, Counterclaims Against Plaintiffs, and Third-Party Claims Against Charles Rizzuti (“Amended Answer”). (Doc. No. 8.) Defendants asserted counterclaims against both Michael Grassi and CFOM for deceptive trade practices and breach of contract (Counts V and VII)

and counterclaims against Michael Grassi individually for business defamation, conversion, and tortious interference with current and prospective business (Counts I, II, and VI). (Id. at 20-22, 25- 28.) In Counts III and IV, Defendants also asserted two declaratory judgment counterclaims against Defendants, in which they sought declarations that (1) all intellectual property in ablation casting that Alotech is using in its business and selling to third parties is owned by Alotech and Plaintiffs have no legally cognizable ownership right in such intellectual property, and (2) Plaintiffs do not have any claim to either an ownership stake in Alotech or a share of Alotech’s profits from its ablation casting technology. (Id. at 23-25.) Finally, in Count VIII, Defendants asserted a third-party claim against Rizzuti, seeking a declaratory judgment that neither CFOM nor Rizzuti individually have any claim to either additional monetary payments from Alotech or any ownership stake in Alotech. (Id. at 28-

29.) Significant discovery ensued from January 2019 to September 2019. The docket reflects that the parties engaged in written discovery and that Defendants produced more than 34,000 pages of documents. (See Doc. Nos. 24-13; 24-14; 24-15; 95 at 7.) In addition, multiple depositions were taken, including those of Michael Grassi, John Grassi, and Charles Rizzuti. (Doc. Nos. 24-2 through 24-6.) With regard to expert discovery, Plaintiffs were required to identify any expert witnesses by

4 February 18, 2019. (Doc. No. 15.) It is undisputed that they failed to do so. Defendants, on the other hand, identified an expert witness on February 18, 2019. (Doc. No. 18.) On June 17, 2019, Defendants moved for summary judgment as to all six claims in Plaintiffs’ Complaint, as well as Defendants’ three declaratory judgment claims. (Doc. No. 24.) Plaintiffs and Rizzuti filed a brief in opposition on July 16, 2019, to which Defendants replied on July 30, 2019. (Doc. Nos. 26, 30.) This Court then extended the discovery deadline until October 7, 2019. (Aug. 6,

2019 Non-Doc. Order.) An additional status conference was held on October 21, 2019. (Doc. No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Thomas v. Amerada Hess Corporation
393 F. Supp. 58 (M.D. Pennsylvania, 1975)
Rosenthal v. Bridgestone/Firestone, Inc.
217 F. App'x 498 (Sixth Circuit, 2007)
Grover v. Eli Lilly & Co.
33 F.3d 716 (Sixth Circuit, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
Grassi v. Grassi, Counsel Stack Legal Research, https://law.counselstack.com/opinion/grassi-v-grassi-ohnd-2022.